Cutaneous Management after Extravasation of High-Concentrated Amino Acid Solution Administered for Renal Protection in PRRT by Chaninart Sakulpisuti, Wichana Chamroonrat, Supatporn Tepmongkol

Subjects: “…peptide receptor radionuclide therapy (PRRT)…”
Get full text

Complete loss of E-cadherin expression in a rare case of metastatic malignant meningioma: a case report by Dominik Lisowski, Philipp E. Hartrampf, Natalie Hasenauer, Vera Nickl, Camelia-Maria Monoranu, Jörg Tamihardja

Subjects: Get full text

Extravasation of [177Lu]Lu-DOTATOC: case report and discussion by Anne Kirstine Arveschoug, Anne Charlotte Bekker, Peter Iversen, Henrik Bluhme, Gerda Elisabeth Villadsen, Peter Frøhlich Staanum

Subjects: Get full text

Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management by Alexandre Chicheportiche, Simona Ben-Haim, Simona Grozinsky-Glasberg, Kira Oleinikov, Amichay Meirovitz, David J. Gross, Jeremy Godefroy

Subjects: “…Peptide receptor radionuclide therapy (PRRT)…”
Get full text

Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu/²²⁵AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refrac... by Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, Andreas Kjaer, Richard P. Baum

Subjects: Get full text

Malignant Paraganglioma With Calvarial Metastases Presenting With Recurrent Catecholamine-Induced Cardiomyopathy by Beatrice A. Brumley, MD, Run Yu, MD, PhD, Shadfar Bahri, MD, Jane Rhyu, MD

Subjects: Get full text

Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT by Kevin Zwirtz, Juliane Hardt, Güliz Acker, Alexander D. J. Baur, Marianne Pavel, Kai Huang, Winfried Brenner, Vikas Prasad

Subjects: “…peptide receptor radionuclide therapy (PRRT)…”
Get full text

GRPR-targeting radiotheranostics for breast cancer management by Alice D’Onofrio, Swantje Engelbrecht, Tilman Läppchen, Axel Rominger, Eleni Gourni

Subjects: Get full text

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists by Mengqi Shi, Mengqi Shi, Vivianne Jakobsson, Vivianne Jakobsson, Lukas Greifenstein, Pek-Lan Khong, Pek-Lan Khong, Xiaoyuan Chen, Xiaoyuan Chen, Xiaoyuan Chen, Xiaoyuan Chen, Xiaoyuan Chen, Richard P. Baum, Jingjing Zhang, Jingjing Zhang, Jingjing Zhang

Subjects: Get full text

Predictive power of the post-treatment scans after the initial or first two courses of [177Lu]-DOTA-TATE by Alexandre Chicheportiche, Simona Grozinsky-Glasberg, David J. Gross, Yodphat Krausz, Asher Salmon, Amichay Meirovitz, Nanette Freedman, Jeremy Godefroy

Subjects: “…Peptide receptor radionuclide therapy (PRRT)…”
Get full text

Bioprosthetic valve monitoring in patients with carcinoid heart disease by Kevin A. Honan, Saamir Hassan, Anita Deswal, Joerg Herrmann, Juhee Song, Dominique Monlezun, Daniel Halperin, Armeen Mahvash, Arvind Dasari, Efstratios Koutroumpakis, Mehmet Akay, Dinu-Valentin Balanescu, Ismael Salas de Armas, Manish Patel, Sriram Nathan, Biswajit Kar, Konstantinos Marmagkiolis, Juan Lopez-Mattei, Jay Patel, Igor Gregoric, James Yao, Cezar A. Iliescu

Subjects: Get full text

“Cold” Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy by Sara Massironi, Manuela Albertelli, Iderina Hasballa, Piero Paravani, Diego Ferone, Antongiulio Faggiano, Silvio Danese

Subjects: Get full text

The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next? by Philip E. Harris, Konstantin Zhernosekov

Subjects: “…peptide receptor radionuclide therapy (PRRT)…”
Get full text

Long-term prognostic factors for PRRT in neuroendocrine tumors by Nils Florian Trautwein, Nils Florian Trautwein, Nils Florian Trautwein, Johannes Schwenck, Johannes Schwenck, Johannes Schwenck, Johann Jacoby, Gerald Reischl, Gerald Reischl, Francesco Fiz, Francesco Fiz, Lars Zender, Lars Zender, Lars Zender, Lars Zender, Helmut Dittmann, Helmut Dittmann, Martina Hinterleitner, Martina Hinterleitner, Martina Hinterleitner, Christian la Fougère, Christian la Fougère, Christian la Fougère, Christian la Fougère

Subjects: Get full text

Palmitic Acid-Conjugated Radiopharmaceutical for Integrin α_vβ₃-Targeted Radionuclide Therapy by Guangjie Yang, Hannan Gao, Chuangwei Luo, Xiaoyu Zhao, Qi Luo, Jiyun Shi, Fan Wang

Subjects: Get full text

Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT) by Alexandre Chicheportiche, Faozi Artoul, Arnon Schwartz, Simona Grozinsky-Glasberg, Amichay Meirovitz, David J. Gross, Jeremy Godefroy

Subjects: “…Peptide receptor radionuclide therapy (PRRT)…”
Get full text

Combination of [¹⁷⁷Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenogr... by Marina Simón, Jesper Tranekjær Jørgensen, Harshvardhan A. Khare, Camilla Christensen, Carsten Haagen Nielsen, Andreas Kjaer

Subjects: Get full text

Lutathera^® Orphans: State of the Art and Future Application of Radioligand Therapy with ¹⁷⁷Lu-DOTATATE by Luca Urso, Alberto Nieri, Licia Uccelli, Angelo Castello, Paolo Artioli, Corrado Cittanti, Maria Cristina Marzola, Luigia Florimonte, Massimo Castellani, Sergio Bissoli, Francesca Porto, Alessandra Boschi, Laura Evangelista, Mirco Bartolomei

Subjects: Get full text

The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience by Leandra Piscopo, Emilia Zampella, Fabio Volpe, Valeria Gaudieri, Carmela Nappi, Erica Di Donna, Stefania Clemente, Antonio Varallo, Mariano Scaglione, Alberto Cuocolo, Michele Klain

Subjects: Get full text

Lutathera^®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy by Ute Hennrich, Klaus Kopka

Subjects: Get full text